The drug "Cromohexal" instruction refers to the category of anti-allergic drugs. The medication is highly effective and well tolerated.
Cromohexal (nasal spray) is used to relieve symptoms of allergic rhinitis (seasonal and year-round). The drug in the form of ophthalmic drops is prescribed for manifestations of acute or chronic conjunctivitis of an atopic nature. The active substance is cromoglicic acid disodium salt.
The active component has a stabilizing effect on the membranes in basophilic granulocytes, and also delays the entry of potassium ions into the cells. Due to this, the medicine "Cromohexal" prevents degranulation and the release of inflammatory and allergic mediators (histamine, bradykinikin and others) into the blood.
After application, intranasally (in the nose), less than seven and a half percent of the administered dosage is absorbed and enters the systemic circulation. Withdrawal of the drug "Cromhexal" is carried out in a day with urine and bile (in the same amount). The drug is not exposed to metabolism in the body.
In the form of eye drops, the drug is applied one drop in each eye. Frequency of use - no more than four times a day. The dosage for children and adults is the same.
The drug "Cromohexal" (spray) instruction recommends the use of one dose in each nostril. Frequency of use - no more than four times a day.
The drug "Cromohexal" instruction recommends using after stopping (eliminating) the symptoms of the disease (allergic conjunctivitis or rhinitis) during the entire period of activity of allergens (house dust, pollen, fluff and other things). In the chronic course of pathology, only a specialist individually can determine the duration of a therapeutic course.
To the side effects of Cromohexal, the instructions include (when injected into the nose) nausea, irritation of the mucous membrane in the nasal cavity, and skin rash.
The drug is contraindicated in case of hypersensitivity to the components.
The experiments conducted on animals did not reveal the teratogenic effect of the drug Cromohexal on the fetus. However, adequate studies involving humans have not been conducted. In this regard, the medicine "Cromohexal" instruction does not recommend use during gestation.
The ability of cromoglycic acid to be excreted in breast milk has been established. Despite the low concentration of the substance, it is not recommended to prescribe the drug during the period of feeding. If it is necessary to use the medicine by a nursing woman, the question of the suspension of lactation should be decided.
In the presence of ophthalmic diseases, which are indications for the use of Cromohexal (drops), an ophthalmologist should determine the appropriateness of using the medication in parallel with wearing lenses. In the absence of contraindications for the use of eye drops, you need to know that the benzalkonium chloride component included in the product has the ability to change the color of the lenses. In addition, they should be removed before instillation. It is allowed to set the lenses back after fifteen minutes after instillation (instillation).
Cromohexal (ophthalmic drops) may cause blurred gaze. In this regard, it is not recommended immediately after instillation to begin activities that require high definition vision.
The drug should be stored at a temperature of no more than twenty-five degrees.
Despite the fact that reviews about Cromohexal (spray) are positive in most cases, it is recommended to read the annotation and consult a doctor before use.